| Supplementary Financial Information (unaudited) |
Supplementary Financial Information (unaudited)
The Company uses a 52- or 53-week fiscal year ending on the last Saturday in December. All quarters of 2020 and 2019 consisted of 13 weeks.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions, except per share amounts) |
|
2020 |
|
2019 |
|
Dec 26 |
|
Sep 26 |
|
June 27 |
|
Mar 28 |
|
Dec 28 |
|
Sep 28 |
|
June 29 |
|
Mar 30 |
| Net revenue |
$ |
3,244 |
|
|
$ |
2,801 |
|
|
$ |
1,932 |
|
|
$ |
1,786 |
|
|
$ |
2,127 |
|
|
$ |
1,801 |
|
|
$ |
1,531 |
|
|
$ |
1,272 |
|
| Cost of sales |
1,793 |
|
|
1,571 |
|
|
1,084 |
|
|
968 |
|
|
1,178 |
|
|
1,024 |
|
|
910 |
|
|
751 |
|
| Gross profit |
1,451 |
|
|
1,230 |
|
|
848 |
|
|
818 |
|
|
949 |
|
|
777 |
|
|
621 |
|
|
521 |
|
| Research and development |
573 |
|
|
508 |
|
|
460 |
|
|
442 |
|
|
395 |
|
|
406 |
|
|
373 |
|
|
373 |
|
| Marketing, general and administrative |
308 |
|
|
273 |
|
|
215 |
|
|
199 |
|
|
206 |
|
|
185 |
|
|
189 |
|
|
170 |
|
| Licensing gain |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(60) |
|
| Operating income |
570 |
|
|
449 |
|
|
173 |
|
|
177 |
|
|
348 |
|
|
186 |
|
|
59 |
|
|
38 |
|
| Interest expense |
(9) |
|
|
(11) |
|
|
(14) |
|
|
(13) |
|
|
(18) |
|
|
(24) |
|
|
(25) |
|
|
(27) |
|
| Other income (expense), net |
(15) |
|
|
(37) |
|
|
1 |
|
|
4 |
|
|
(125) |
|
|
(36) |
|
|
3 |
|
|
(7) |
|
| Income before income taxes |
546 |
|
|
401 |
|
|
160 |
|
|
168 |
|
|
205 |
|
|
126 |
|
|
37 |
|
|
4 |
|
Income tax provision (benefit) (1)
|
(1,232) |
|
|
12 |
|
|
4 |
|
|
6 |
|
|
35 |
|
|
7 |
|
|
2 |
|
|
(13) |
|
| Equity income (loss) in investee |
3 |
|
|
1 |
|
|
1 |
|
|
— |
|
|
— |
|
|
1 |
|
|
— |
|
|
(1) |
|
| Net income |
$ |
1,781 |
|
|
$ |
390 |
|
|
$ |
157 |
|
|
$ |
162 |
|
|
$ |
170 |
|
|
$ |
120 |
|
|
$ |
35 |
|
|
$ |
16 |
|
| Earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
$ |
1.48 |
|
|
$ |
0.33 |
|
|
$ |
0.13 |
|
|
$ |
0.14 |
|
|
$ |
0.15 |
|
|
$ |
0.11 |
|
|
$ |
0.03 |
|
|
$ |
0.01 |
|
| Diluted |
$ |
1.45 |
|
|
$ |
0.32 |
|
|
$ |
0.13 |
|
|
$ |
0.14 |
|
|
$ |
0.15 |
|
|
$ |
0.11 |
|
|
$ |
0.03 |
|
|
$ |
0.01 |
|
| Shares used in per share calculation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
1,205 |
|
|
1,184 |
|
|
1,174 |
|
|
1,170 |
|
|
1,140 |
|
|
1,097 |
|
|
1,084 |
|
|
1,044 |
|
| Diluted |
1,226 |
|
|
1,215 |
|
|
1,227 |
|
|
1,224 |
|
|
1,188 |
|
|
1,117 |
|
|
1,109 |
|
|
1,094 |
|
(1) During the fourth quarter of 2020, the Company recognized a $1.3 billion income tax benefit upon the release of a portion of the valuation allowance on U.S. deferred tax assets.
|